fluoxetine has been researched along with oxadiazoles in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Cunningham, JR; Hogg, JE; Hutson, PH; Longmore, J; Murray, F; Pearce, D; Razzaque, Z; Saywell, K; Tricklebank, MD | 1 |
| Cistarelli, L; Gobert, A; Millan, MJ; Rivet, JM | 1 |
| Millan, MJ; Perrin-Monneyron, S | 1 |
| Gean, PW; Lu, KT | 1 |
| Barton, CL; Hutson, PH | 1 |
| Matsumoto, M; Miyamoto, A; Mori, K; Togashi, H; Ueno, K; Yoshioka, M | 1 |
| Knobelman, DA; Kung, HF; Lucki, I | 1 |
| Dawson, LA; Nguyen, HQ | 1 |
| Cooper, J; Greenslade, RG; Mitchell, SN | 1 |
| Jeong, MS; Kim, CJ; Kim, KW; Park, EY; Park, JW; Shin, BS; Shin, MS; Woo, RS; Zhao, RJ | 1 |
| Adnot, S; Eddahibi, S; Hamon, M; Marcos, E; Nosjean, A; Pham, MH; Raffestin, B | 1 |
| Araujo-Alvarez, JM; Delgado, A; Oviedo-Chávez, A; Querejeta, E; Quiñones-Cárdenas, AR | 1 |
| Ansorge, M; Dulawa, SC; Geyer, MA; Gingrich, JA; Hen, R; Holick Pierz, KA; Masten, VL; Shanahan, NA; Waeber, C | 1 |
| Jiang, Z; Shang, J; Wang, W; Zhang, H; Zhang, L | 1 |
| Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G | 1 |
| Corrêa, FM; Joca, SR; Resstel, LB; Scopinho, AA; Stanquini, LA | 1 |
| García-Domingo, M; García-Pedraza, JÁ; Gómez-Roso, M; López, C; Martín, ML; Morán, A | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
18 other study(ies) available for fluoxetine and oxadiazoles
| Article | Year |
|---|---|
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig.
Topics: Animals; Biogenic Monoamines; Brain; Dyskinesia, Drug-Induced; Electric Stimulation; Fluoxetine; Guinea Pigs; Humans; In Vitro Techniques; Male; Methiothepin; Oxadiazoles; Paroxetine; Piperazines; Raphe Nuclei; Serotonin Antagonists; Synaptic Transmission; Tryptophan | 1995 |
Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
Topics: Animals; Drug Synergism; Fluoxetine; Frontal Lobe; Male; Microdialysis; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |
Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
Topics: Animals; Antidepressive Agents, Second-Generation; Drug Synergism; Fluoxetine; Male; Oxadiazoles; Penile Erection; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1997 |
Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Barium; Epilepsy; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Ketanserin; Male; Membrane Potentials; Metergoline; Neurons; Oxadiazoles; Picrotoxin; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Tryptamines | 1998 |
Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Enzyme Inhibitors; Fluoxetine; Hippocampus; Hydrazines; Male; Oxadiazoles; Paroxetine; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |
Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Male; Microdialysis; Oligonucleotides, Antisense; Oxadiazoles; Piperazines; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Time Factors | 1999 |
Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors.
Topics: Animals; Autoreceptors; Corpus Striatum; Fenfluramine; Fluoxetine; Male; Mice; Microdialysis; Oxadiazoles; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Tetrahydronaphthalenes | 2000 |
The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
Topics: Animals; Autoreceptors; Drug Synergism; Extracellular Space; Fluoxetine; Male; Microdialysis; Oxadiazoles; Pindolol; Piperazines; Propanolamines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2000 |
LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Topics: Administration, Oral; Animals; Cyclic S-Oxides; Dose-Response Relationship, Drug; Extracellular Space; Female; Fenfluramine; Fluoxetine; Frontal Lobe; Guinea Pigs; Hypothalamus; Injections, Intraperitoneal; Male; Oxadiazoles; Paroxetine; Piperazines; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tetrodotoxin; Thiadiazines; Time Factors | 2001 |
Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.
Topics: Adolescent; Adult; Arginine; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Ganglionic Stimulants; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Male; Mecamylamine; Methylene Blue; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Antagonists; Nitrendipine; Nitric Oxide Synthase; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Purinones; Quinoxalines; Tetrodotoxin; Tritium; Tubocurarine | 2002 |
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Topics: Analysis of Variance; Animals; Carrier Proteins; Chronic Disease; Citalopram; Disease Models, Animal; Fluoxetine; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Oxadiazoles; Piperazines; Pulmonary Artery; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric | 2003 |
In vivo effects of local activation and blockade of 5-HT1B receptors on globus pallidus neuronal spiking.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Anesthesia; Animals; Behavior, Animal; Denervation; Fluoxetine; Globus Pallidus; Male; Methiothepin; Neurons; Oxadiazoles; Piperazines; Pyridines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines | 2005 |
Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Female; Fluoxetine; Globus Pallidus; Indoles; Mice; Mice, Inbred BALB C; Mice, Knockout; Motor Activity; Oxadiazoles; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1B; Reflex, Startle; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra | 2009 |
Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Depression; Fluoxetine; Interferon-alpha; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxadiazoles; Piperazines; Pyridines; Quinoxalines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2010 |
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fetus; Fluoxetine; Hemodynamics; Hypertension, Pulmonary; Hysterotomy; Indoles; Ketanserin; Lung; Oxadiazoles; Piperazines; Pregnancy; Pulmonary Artery; Pyridines; Receptors, Serotonin; rho-Associated Kinases; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep; Vascular Resistance | 2011 |
Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats.
Topics: Aminopyridines; Animals; Benzamides; Dose-Response Relationship, Drug; Eating; Fasting; Fluoxetine; Indoles; Male; Microinjections; Motor Activity; Oxadiazoles; Piperazines; Prefrontal Cortex; Pyridines; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Fluoxetine oral treatment discloses 5-HT
Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Bradycardia; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoxetine; Heart; Heart Rate; Humans; Oxadiazoles; Phenols; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Sulfonamides; Tryptamines; Vagus Nerve | 2019 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |